{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T11:12:44Z","timestamp":1772190764108,"version":"3.50.1"},"reference-count":28,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1534,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1111\/j.1600-0897.2011.01031.x","type":"journal-article","created":{"date-parts":[[2011,6,20]],"date-time":"2011-06-20T09:43:27Z","timestamp":1308563007000},"page":"404-409","source":"Crossref","is-referenced-by-count":22,"title":["Anti-Prothrombin Antibodies are Associated with Adverse Pregnancy Outcome"],"prefix":"10.1111","volume":"66","author":[{"given":"Luca","family":"Marozio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonella","family":"Curti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Botta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilie M.","family":"Canuto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Loredana","family":"Salton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna Maria","family":"Tavella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Benedetto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2011,6,20]]},"reference":[{"key":"10.1111\/j.1600-0897.2011.01031.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1600-0897.2011.01031.x-BIB2|cit2","first-page":"632","article-title":"Prevalence and clinical significance of antiprothrombin antibodies in patients with systemic lupus erythematosus or with primary antiphospholipid syndrome","volume":"85","author":"Munoz-Rodriguez","year":"2000","journal-title":"Haematologica"},{"key":"10.1111\/j.1600-0897.2011.01031.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1055\/s-0037-1616083","article-title":"A cross sectional study of antiphospholipid-protein antibodies in patients with venous thromboembolism","volume":"86","author":"Pasquier","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1600-0897.2011.01031.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"61","DOI":"10.5858\/2005-129-61-PACCOA","article-title":"Prevalence and clinical correlation of anti-phospholipid-binding protein antibodies in anticardiolipin-negative patients with systemic lupus erythematosus and women with unexplained recurrent miscarriages","volume":"129","author":"Bizzaro","year":"2005","journal-title":"Arch Pathol Lab Med"},{"key":"10.1111\/j.1600-0897.2011.01031.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1034\/j.1600-0897.2003.01153.x","article-title":"Antiprothrombin antibodies are associated with pregnancy loss in patients with the antiphospholipid syndrome","volume":"49","author":"von Landemberg","year":"2003","journal-title":"Am J Reprod Immunol"},{"key":"10.1111\/j.1600-0897.2011.01031.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1373\/clinchem.2006.073098","article-title":"Increased plasma concentrations of antiprothrombin antibodies in women with recurrent spontaneous abortions","volume":"53","author":"Sabatini","year":"2007","journal-title":"Clin Chem"},{"key":"10.1111\/j.1600-0897.2011.01031.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1182\/blood.V81.10.2618.2618","article-title":"Antiphospholipid antibodies directed against a combination of phospholipid with prothrombin, protein C, or protein S: an explanation for their pathogenic mechanism?","volume":"81","author":"Oosting","year":"1993","journal-title":"Blood"},{"key":"10.1111\/j.1600-0897.2011.01031.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1002\/1529-0131(200003)43:3<557::AID-ANR11>3.0.CO;2-O","article-title":"Prevalence of anti-protein S antibodies in patients with systemic lupus erythematosus","volume":"43","author":"Song","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1111\/j.1600-0897.2011.01031.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1093\/clinchem\/47.6.1008","article-title":"Association between the prevalence of antibodies to \u03b22 glycoprotein 1, prothrombin, protein C, protein S, and annexin V in patients with systemic lupus erythematosus and thrombocytopenic complications","volume":"47","author":"Nojima","year":"2001","journal-title":"Clin Chem"},{"key":"10.1111\/j.1600-0897.2011.01031.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1160\/TH03-03-0151","article-title":"Antibodies directed to protein S in patients with systemic lupus erythematosus: prevalence and clinical significance","volume":"90","author":"Bertolaccini","year":"2003","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1600-0897.2011.01031.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.3324\/haematol.12575","article-title":"IgM anti-protein S antibodies as a risk factor for venous thrombosis","volume":"93","author":"Borrel","year":"2008","journal-title":"Haematologica"},{"key":"10.1111\/j.1600-0897.2011.01031.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.thromres.2008.11.006","article-title":"Acquired activated protein C resistance is associated with IgG antibodies to protein S in patients with systemic lupus erythematosus","volume":"124","author":"Nojima","year":"2009","journal-title":"Thromb Res"},{"key":"10.1111\/j.1600-0897.2011.01031.x-BIB13|cit13","first-page":"67","article-title":"Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. American College of Obstetricians and Gynecologists","volume":"77","author":"ACOG practice bulletin","year":"2002","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1111\/j.1600-0897.2011.01031.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1161\/01.HYP.0000188979.74172.4d","article-title":"Thrombophilia is significantly associated with severe preeclampsia: results of a large-scale, case-controlled study","volume":"46","author":"Mello","year":"2005","journal-title":"Hypertension"},{"key":"10.1111\/j.1600-0897.2011.01031.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1365-2141.2005.05847.x","article-title":"Risk and Economic Assessment of Thrombophilia Screening (TREATS) Study: Thrombophilia in pregnancy; a systematic review","volume":"132","author":"Robertson","year":"2006","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1600-0897.2011.01031.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1182\/blood-2005-04-1710","article-title":"Directing thrombin","volume":"106","author":"Lane","year":"2005","journal-title":"Blood"},{"key":"10.1111\/j.1600-0897.2011.01031.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1055\/s-0037-1614977","article-title":"The role of the tissue factor pathway in the hypercoagulable state in patients with the antiphospholipid syndrome","volume":"79","author":"Amengual","year":"1998","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1600-0897.2011.01031.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1365-2141.2006.06283.x","article-title":"A human monoclonal antiprothrombin antibody is thrombogenic in vivo and upregulates expression of tissue factor and E-selectin on endothelial cells","volume":"135","author":"Vega-Ostertag","year":"2006","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1600-0897.2011.01031.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.ajog.2004.03.001","article-title":"Thrombophilia and pregnancy complications","volume":"191","author":"Kujovich","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"10.1111\/j.1600-0897.2011.01031.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1007\/s12016-007-8055-9","article-title":"Updating on the pathogenic mechanisms of the antiphospholipid antibodies-associated pregnancy loss","volume":"34","author":"Meroni","year":"2008","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1111\/j.1600-0897.2011.01031.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1111\/j.1600-0897.2007.00474.x","article-title":"Placental thrombosis in experimental anticardiolipin antibodies-mediated intrauterine fetal death","volume":"57","author":"Velayuthaprabhu","year":"2007","journal-title":"Am J Reprod Immunol"},{"key":"10.1111\/j.1600-0897.2011.01031.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1126\/science.1111726","article-title":"Latest advances in understanding preeclampsia","volume":"308","author":"Redman","year":"2005","journal-title":"Science"},{"key":"10.1111\/j.1600-0897.2011.01031.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1093\/humrep\/15.8.1830","article-title":"Do placental lesions reflect thrombophilia state in women with adverse pregnancy outcome?","volume":"15","author":"Mousa","year":"2000","journal-title":"Hum Reprod"},{"key":"10.1111\/j.1600-0897.2011.01031.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1161\/HYPERTENSIONAHA.107.104844","article-title":"Severe preeclampsia with and without HELLP differ with regard to placental pathology","volume":"51","author":"Vinnars","year":"2008","journal-title":"Hypertension"},{"key":"10.1111\/j.1600-0897.2011.01031.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1196\/annals.1422.054","article-title":"Pregnancies complicated with antiphospholipid syndrome: the pathogenic mechanism of antiphospholipid antibodies","volume":"1108","author":"Di Simone","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"10.1111\/j.1600-0897.2011.01031.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"7597","DOI":"10.1073\/pnas.95.13.7597","article-title":"Prothrombin deficiency results in embryonic and neonatal lethality in mice","volume":"95","author":"Sun","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1111\/j.1600-0897.2011.01031.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1006\/jaut.2000.0413","article-title":"Should we include anti-prothrombin antibodies in the screening for the antiphospholipid syndrome?","volume":"15","author":"Galli","year":"2000","journal-title":"J Autoimmun"},{"key":"10.1111\/j.1600-0897.2011.01031.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1055\/s-0037-1613293","article-title":"Anti-beta2-glycoprotein 1 and anti-prothrombin antibodies in antiphospholipid-negative patients with thrombosis: a case-control study","volume":"88","author":"Previtali","year":"2002","journal-title":"Thromb Haemost"}],"container-title":["American Journal of Reproductive Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0897.2011.01031.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1600-0897.2011.01031.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,25]],"date-time":"2021-11-25T23:29:02Z","timestamp":1637882942000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0897.2011.01031.x"}},"subtitle":["ANTI-PROTHROMBIN ANTIBODIES AND PREGNANCY"],"short-title":[],"issued":{"date-parts":[[2011,6,20]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,11]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1600-0897.2011.01031.x","relation":{},"ISSN":["1046-7408"],"issn-type":[{"value":"1046-7408","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6,20]]}}}